PPB recalls three common drugs from the Kenyan market
The identified batches include the Lumidol injection, batch Numbers CM4594007, CM4594008, and CM4594009. The drug was manufactured by KamlaAmrut Pharmaceutical in India.
What you need to know:
- Healthcare providers are advised to discontinue prescribing these medications immediately, while patients currently using any of these drugs should consult their healthcare providers for alternative treatment options.
The Pharmacy and Poisons Board (PPB) has today issued an immediate recall of three widely-used pharmaceutical products from the Kenyan market.
The drugs are Augmentin, paracetamol and esomeprazole.
Augmentin is an antibiotic used to treat infections of the urinary tract, respiratory tract, ear, sinuses, and skin, as prescribed by a medical doctor.
The PPB found out that there was a forged batch of Augmentin, batch numbers 8X3K and EU7C, doing rounds in the Kenyan market.
Pain reliever
Paracetamol is an over-the-counter pain reliever and fever reducer used in many households across the country, while Esomeprazole is a prescription medication used to reduce stomach acid production and treat conditions like acid reflux and ulcers.
Healthcare providers are advised to discontinue prescribing these medications immediately, while patients currently using any of these drugs should consult their healthcare providers for alternative treatment options.
The PPB advises all pharmaceutical outlets, healthcare facilities, professionals, and members of the public to immediately stop further distribution, sale, issuing, or use of the flagged batch and return the same to their nearest healthcare facility or respective suppliers.
A batch of paracetamol, a common painkiller available over the counter in pharmacies and hospitals as an injection, has also been identified to have had a colour change, therefore unsuitable for use.
The identified batches include the Lumidol injection, batch Numbers CM4594007, CM4594008, and CM4594009. The drug was manufactured by KamlaAmrut Pharmaceutical in India.
The other batch is the blink injection, batch numbers CS4594005, also manufactured by KamlaAmrut Pharmaceutical LLP, India and CS4594004
The last injection is the Paragen of batch number K4290027 from the same manufacturer. The PPB labelled the recalled paracetamol as substandard and asked members of the public to stop using it.
There was a mix-up of the last drug, where a strip of another drug was found to be part of the S-Prazo (Esomeprazole of 40mg) number SPZ404 batch. Pharmaceutical outlets have since been advised to stop distributing the mentioned drug batch.
